开拓药业有限公司（开拓药业-B，09939）于2026年3月4日发布股份变动月报表，报告期覆盖至2026年2月28日。公告显示，该公司本月并无新增发行、购回或注销行为，股本结构维持稳定。
开拓药业-B普通股注册股本数量继续维持700,000,000股，每股面值为0.0001美元，总注册股本为70,000美元，与上月无异动。已发行股份数同样维持在498,660,100股，库藏股为0股。
公告披露，截至报告期末，公司已满足适用的公众持股量要求。公司同时确认，本月未发生其他与股份期权、可换股票据或其他股权激励相关的变动事宜。公告由公司主席、执行董事及行政总裁童友之签署并确认，相关发行及上市程序均符合香港联交所《上市规则》和相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.